Pfizer cuts 2022 earnings outlook despite strong first-quarter Covid vaccine and antiviral sales

Read Time:6 Second

Pfizer said it sold $13.2 billion of its Covid vaccine and $1.5 billion of its antiviral treatment Paxlovid.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

Our companies' performances were reflective of the S&P 500 firms in aggregate.

Adobe reported third-quarter results on Thursday that beat Wall Street expectations for sales and earnings.

Oracle is projecting higher revenue and capital expenditures as its cloud-computing arm grows.

Investor concerns around the AI boom, coupled with the market's sensitivity to the Fed's next policy move, have caused Wall...

In late 2022, Goldman Sachs began to pivot away from its consumer operations, beginning a series of write-downs related to...

While Oracle becomes more competitive in cloud infrastructure, it's also ensuring that competitors can offer its widely used database to...